-
1
-
-
0022656434
-
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
-
31425
-
Link MP, Miser AW, Green AA et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 31425: 1600-1606.
-
(1986)
N Engl J Med
, pp. 1600-1606
-
-
Link, M.P.1
Miser, A.W.2
Green, A.A.3
-
2
-
-
0027946691
-
Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases
-
Ward WG, Mikaelian K, Dorey F et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol 1994; 12: 1849-1858.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1849-1858
-
-
Ward, W.G.1
Mikaelian, K.2
Dorey, F.3
-
3
-
-
0037089598
-
High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study
-
Fagioli F, Aglietta M, Tienghi A et al. High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. J Clin Oncol 2002; 20: 2150-2156.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2150-2156
-
-
Fagioli, F.1
Aglietta, M.2
Tienghi, A.3
-
4
-
-
3543081513
-
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas
-
Kasper B, Lehnert T, Bernd L et al. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant 2004; 34: 37-41.
-
(2004)
Bone Marrow Transplant
, vol.34
, pp. 37-41
-
-
Kasper, B.1
Lehnert, T.2
Bernd, L.3
-
5
-
-
59149095843
-
Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients
-
Bielack SS, Kempf-Bielack B, Branscheid D et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 2009; 27: 557-565.
-
(2009)
J Clin Oncol
, vol.27
, pp. 557-565
-
-
Bielack, S.S.1
Kempf-Bielack, B.2
Branscheid, D.3
-
7
-
-
0031417685
-
A dose-controlled study of 153Smethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases
-
Resche I, Chatal JF, Pecking A et al. A dose-controlled study of 153Smethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 1997; 33: 1583-1591.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1583-1591
-
-
Resche, I.1
Chatal, J.F.2
Pecking, A.3
-
8
-
-
0034960433
-
Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis
-
Serafini AN. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis. Q J Nucl Med 2001; 45: 91-99.
-
(2001)
Q J Nucl Med
, vol.45
, pp. 91-99
-
-
Serafini, A.N.1
-
9
-
-
0036137678
-
High-dose samarium-153 ethylenediamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases
-
Anderson PM, Wiseman GA, Dispenzieri A et al. High-dose samarium-153 ethylenediamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 2002; 20: 189-196.
-
(2002)
J Clin Oncol
, vol.20
, pp. 189-196
-
-
Anderson, P.M.1
Wiseman, G.A.2
Dispenzieri, A.3
-
10
-
-
26444443542
-
Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma
-
Anderson PM, Wiseman GA, Erlandson L et al. Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Clin Cancer Res 2005; 11: 6895-6900.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6895-6900
-
-
Anderson, P.M.1
Wiseman, G.A.2
Erlandson, L.3
-
11
-
-
33644837672
-
Neoadjuvant chemotherapy with highdose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups
-
Ferrari S, Smeland S, Mercuri M et al. Neoadjuvant chemotherapy with highdose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23: 8845-8852.
-
(2005)
J Clin Oncol
, vol.23
, pp. 8845-8852
-
-
Ferrari, S.1
Smeland, S.2
Mercuri, M.3
-
12
-
-
0036189675
-
EORTC Soft Tissue and Bone Sarcoma Group. Progression-free rate as the principal end-point for phase II trials in soft tissue sarcomas
-
Van Glabbeke M, Verweeij J, Judson I, Nielsen OS. EORTC Soft Tissue and Bone Sarcoma Group. Progression-free rate as the principal end-point for phase II trials in soft tissue sarcomas. Eur J Cancer 2002; 38: 543-549.
-
(2002)
Eur J Cancer
, vol.38
, pp. 543-549
-
-
Van Glabbeke, M.1
Verweeij, J.2
Judson, I.3
Nielsen, O.S.4
-
13
-
-
34247586993
-
Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial
-
Dileo P, Morgan JA, Zahrieh D et al. Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas: results of a phase II trial. Cancer 2007; 109: 1863-1869.
-
(2007)
Cancer
, vol.109
, pp. 1863-1869
-
-
Dileo, P.1
Morgan, J.A.2
Zahrieh, D.3
-
14
-
-
33646401788
-
RECIST revisited: a review of validation studies on tumour assessment
-
Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 2006; 42: 1031-1039.
-
(2006)
Eur J Cancer
, vol.42
, pp. 1031-1039
-
-
Therasse, P.1
Eisenhauer, E.A.2
Verweij, J.3
-
15
-
-
10744228140
-
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
-
Trotti A, Colevas AD, Setser A et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003; 13: 176-181.
-
(2003)
Semin Radiat Oncol
, vol.13
, pp. 176-181
-
-
Trotti, A.1
Colevas, A.D.2
Setser, A.3
-
16
-
-
0026750068
-
Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer
-
Farhanghi M, Holmes RA, Volkert WA et al. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer. J Nucl Med 1992; 33: 1451-1458.
-
(1992)
J Nucl Med
, vol.33
, pp. 1451-1458
-
-
Farhanghi, M.1
Holmes, R.A.2
Volkert, W.A.3
-
17
-
-
0027958545
-
Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases
-
Bayouth JE, Macey DJ, Kasi LP, Fossella VF. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases. J Nucl Med 1994; 35: 63-69.
-
(1994)
J Nucl Med
, vol.35
, pp. 63-69
-
-
Bayouth, J.E.1
Macey, D.J.2
Kasi, L.P.3
Fossella, V.F.4
-
18
-
-
14844362344
-
Dosimetry of internal emitters
-
Sgouros G. Dosimetry of internal emitters. J Nucl Med 2005; 46: 18S-27S.
-
(2005)
J Nucl Med
, vol.46
-
-
Sgouros, G.1
-
19
-
-
0027253922
-
Samarium-153-EDTMP biodistribution and dosimetry estimation
-
Eary JF, Collins C, Stabin M et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 1993; 34: 1031-1036.
-
(1993)
J Nucl Med
, vol.34
, pp. 1031-1036
-
-
Eary, J.F.1
Collins, C.2
Stabin, M.3
-
21
-
-
0014559581
-
Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom
-
MIRD Pamphlet No. 5
-
Snyder WS, Fisher HL, Jr, Ford MR, Warner GG. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J Nucl Med 1969; 10: 5-52. MIRD Pamphlet No. 5.
-
(1969)
J Nucl Med
, vol.10
, pp. 5-52
-
-
Snyder, W.S.1
Fisher Jr., H.L.2
Ford, M.R.3
Warner, G.G.4
-
22
-
-
0023267570
-
Radiation dose calculations in persons receiving injection of Sm-153-EDTMP
-
Logan K, Volkert W, Holmes R. Radiation dose calculations in persons receiving injection of Sm-153-EDTMP. J Nucl Med 1987; 28: 505-509.
-
(1987)
J Nucl Med
, vol.28
, pp. 505-509
-
-
Logan, K.1
Volkert, W.2
Holmes, R.3
-
23
-
-
33845382806
-
Non parametric estimation from incomplete observation
-
Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
24
-
-
0000336139
-
Regression models and life tables
-
Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-202.
-
(1972)
J R Stat Soc
, vol.34
, pp. 187-202
-
-
Cox, D.R.1
-
25
-
-
84972545970
-
A survey of exact inference for contingency tables
-
Agresti A. A survey of exact inference for contingency tables. Stat Sci 1992; 7: 131-177.
-
(1992)
Stat Sci
, vol.7
, pp. 131-177
-
-
Agresti, A.1
-
26
-
-
33748125999
-
Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients
-
Bacci G, Longhi A, Bertoni F et al. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients. Acta Orthop 2006; 77: 938-943.
-
(2006)
Acta Orthop
, vol.77
, pp. 938-943
-
-
Bacci, G.1
Longhi, A.2
Bertoni, F.3
-
27
-
-
0037440140
-
Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma
-
Aung L, Gorlick R, Healey JH et al. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma. J Clin Oncol 2003; 21: 342-348.
-
(2003)
J Clin Oncol
, vol.21
, pp. 342-348
-
-
Aung, L.1
Gorlick, R.2
Healey, J.H.3
-
28
-
-
0345707587
-
Single and multiple metachronous osteosarcoma tumors after therapy
-
Jaffe N, Pearson P, Yasko AW et al. Single and multiple metachronous osteosarcoma tumors after therapy. Cancer 2003; 98: 2457-2466.
-
(2003)
Cancer
, vol.98
, pp. 2457-2466
-
-
Jaffe, N.1
Pearson, P.2
Yasko, A.W.3
-
29
-
-
66649106084
-
Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma
-
Loeb DM, Garrett-Mayer E, Hobbs RF et al. Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma. Cancer 2009; 115: 2514-2522.
-
(2009)
Cancer
, vol.115
, pp. 2514-2522
-
-
Loeb, D.M.1
Garrett-Mayer, E.2
Hobbs, R.F.3
-
30
-
-
78649594834
-
Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma
-
Loeb DM, Hobbs RF, Okoli A et al. Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma. Cancer 2010; 116: 5470-5478.
-
(2010)
Cancer
, vol.116
, pp. 5470-5478
-
-
Loeb, D.M.1
Hobbs, R.F.2
Okoli, A.3
-
31
-
-
33644874921
-
Intraorgan biodistribution and dosimetry of 153Sm-ethylene-diaminetetramethylene phosphonate in juvenile rabbit tibia: implication for targeted radiotherapy of osteosarcoma
-
Essman SC, Lewis MR, Miller WH. Intraorgan biodistribution and dosimetry of 153Sm-ethylene-diaminetetramethylene phosphonate in juvenile rabbit tibia: implication for targeted radiotherapy of osteosarcoma. J Nucl Med 2005; 46: 2076-2082.
-
(2005)
J Nucl Med
, vol.46
, pp. 2076-2082
-
-
Essman, S.C.1
Lewis, M.R.2
Miller, W.H.3
-
32
-
-
0242267007
-
The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning
-
Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat 2003; 2: 427-436.
-
(2003)
Technol Cancer Res Treat
, vol.2
, pp. 427-436
-
-
Kramer, M.1
Weyrather, W.K.2
Scholz, M.3
-
33
-
-
33746707858
-
High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
-
Bruland ØS, Nilsson S, Fisher DR, Larsen RH. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?. Clin Cancer Res 2006; 12(20 Pt 2): 6250s-6257s.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.20 PART 2
-
-
Bruland, Ø.S.1
Nilsson, S.2
Fisher, D.R.3
Larsen, R.H.4
|